© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
September 30, 2020
This approval makes the drug the first of its kind to treat polyarticular juvenile idiopathic arthritis and psoriatic arthritis in a pediatric population.
September 18, 2020
Findings indicate placebo responses are more than a psychological placebo effect.
September 14, 2020
Rheumatologists and OB-GYNs must communicate openly with each other and to patients with rheumatic diseases who are considering pregnancy.
September 13, 2020
In the MONARCH OLE study, more than 50% of patients with rheumatoid arthritis who had low or inadequate response to adalimumab and switched to sarilumab experienced an improvement in disease activity.
Patient assessments measured fatigue, disease activity, global spinal pain, and spinal pain at night.
September 12, 2020
A majority of patients with the condition are on azathioprine or mycophenolate mofetil and mycophenolic acid.
September 11, 2020
Filgotinib was well-tolerated and sustained efficacy in a 52-week extension study.
An expert discusses the risks that rheumatic diseases pose for pregnancies as well as the conversations rheumatologists need to have with their patients.
A post-hoc analysis of 3 randomized controlled trials reports on the associations between the IL-6 inhibitor and unacceptable or refractory pain.
Other measures, like home oxygen dependency, all-cause mortality, and hospitalization for respiratory failures rates, had no apparent association with RF and/or ACPA status